Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (10): 40-45.doi: 10.6040/j.issn.1671-7554.0.2018.1013

Previous Articles    

Detection of circulating tumor cell: actualities and challenges

CUI Wei, ZHANG Yujuan   

  1. Department of Clinical Laboratory, National Cancer Center;
    National Clinical Research Center for Cancer;
    Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2018-09-03 Published:2022-09-27

PDF (PC)

187

Abstract: Circulating tumor cell(CTC), as a non-invasive and real-time means of monitoring curative effects, has a potential clinical application. However, due to its distinctive characteristics, the detection of circulating tumer cell is still challenging. This paper will review the actualities and challenges of CTC detection, in order that it may eventually be widely applied in clinical practice.

Key words: Circulating tumor cell, Enrichment, Identification, Standardized management

CLC Number: 

  • R73-37
[1] Hunter K, Amin R, Deasy S, et al. Genetic insights into the morass of metastatic heterogeneity[J]. Nat Rev Cancer, 2018, 18(4): 211-223.
[2] Hiley C, de Bruin E, McGranahan N, et al. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine[J]. Genome Biol, 2014, 15(8): 453-465.
[3] Woo D, Yu M. Circulating tumor cells as “liquid biopsies” to understand cancer metastasis[J]. Transl Res, 2018. doi:10.1016/j.trsl.2018.07.003.
[4] Russo G, Bier S, Hennenlotter J, et al. Expression of tumour progression-associated genes in circulating tumour cells of patients at different stages of prostate cancer[J]. BJU Int, 2018, 122(1): 152-159.
[5] 乔雪峰, 张玉娟, 崔巍. 循环肿瘤细胞致肿瘤血行转移研究进展[J]. 协和医学杂志, 2014,5(3): 331-334.
[6] Ignatiadis M, Lee M, Jeffrey S. Circulating tumor cells and circulating tumor DNA: Challenges and opportunities on the path to clinical utility[J]. Clin Cancer Res, 2015, 21(21): 4786-4800.
[7] Ortiz V, Yu M. Analyzing circulating tumor cells one at a time[J]. Trends Cell Biol, 2018. doi:10.1016/j.tcb. 2018.05.004.
[8] 陈锋, 吴玥, 崔巍. 液体活检走进临床有多远[J]. 中华医学杂志, 2017, 97(34): 2641-2645.
[9] Zhang Y, Wang F, Ning N, et al. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer[J]. Int J Cancer, 2015, 136(5): 1228-1233.
[10] Chen Q, Ge F, Cui W, et al. Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging[J]. Clin Chim Acta, 2013, 419: 57-61. doi:10.1016/j.cca.2013.01.015.
[11] Ning N, Zhan T, Zhang Y, et al. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization[J]. Clin Chim Acta, 2014, 433(10): 69-75.
[12] Liu H, Triboulet M, Zia A, et al. Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection[J]. NPJ Genom Med, 2017, 2: 34-46. doi: 10.1038/s41525-017-0034-3.
[13] Cho H, Kim J, Song H, et al. Microfluidic technologies for circulating tumor cell isolation[J]. Analyst, 2018, 143(13): 2936-2970.
[14] Paoletti C, Cani A, Larios J, et al. Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms[J]. Cancer Res, 2018, 78(4): 1110-1122.
[15] Alva A, Friedlander T, Clark M, et al. Circulating tumor cells as potential biomarkers in bladder cancer[J]. J Urol, 2015, 194(3): 790-798.
[16] Miller M, Robinson P, Wagner C, et al. The parsortixTM cell separation system-a versatile liquid biopsy platform[J]. Cytometry A, 2018. doi: 10.1002/cyto.a.23571.
[17] Tong B, Xu Y, Zhao J, et al. Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy[J]. Oncotarget, 2017, 8(49): 86615-86624.
[18] Wang W, Wan L, Wu S, et al. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis[J]. Cell Oncol(Dordr), 2018. doi:10.1007/s13402-018-0386-4.
[19] Qi L, Xiang B, Wu F, et al. Circulating tumor cells undergoing emt provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma[J]. Cancer Res, 2018, 78(16): 4731-4744.
[20] Jin X, Zhu L, Qian K, et al. Circulating tumor cells in early stage lung adenocarcinoma: a case series report and literature review[J]. Oncotarget, 2017, 8(14): 23130-23141.
[21] Lee Y, Guan G, Bhagat A. ClearCell® FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells[J]. Cytometry A, 2018. doi: 10.1002/cyto.a.23507.
[22] Winer-Jones J, Vahidi B, Arquilevich N, et al. Circulating tumor cells: clinically relevant molecular access based on a novel CTC flow cell[J]. PLoS One, 2014, 9(1): e86717. doi:10.1371/journal.pone.0086717.
[23] Hüsemann Y, Geigl J, Schubert F, et al. Systemic spread is an early step in breast cancer[J]. Cancer Cell, 2008, 13(1): 58-68.
[24] Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients[J]. Cancer Cell, 2013, 23(5): 573-581.
[25] Leroy S, Benzaquen J, Mazzetta A, et al. Circulating tumour cells as a potential screening tool for lung cancer(the AIR study): protocol of a prospective multicentre cohort study in France[J]. BMJ Open, 2017, 7(12): e018884.
[26] Ilie M, Hofman V, Long-Mira E, et al. “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease[J]. PLoS One, 2014, 9(10): e111597. doi:10.1371/journal.pone.0111597.
[27] Chiang A, Massagué J. Molecular basis of metastasis[J]. N Engl J Med, 2008, 359(26): 2814-2823.
[28] Sandri M, Zorzino L, Cassatella M, et al. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery[J]. Ann Surg Oncol, 2010, 17(6): 1539-1545.
[29] Zhang Q, Shan F, Li Z, et al. A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer[J]. J Transl Med, 2018, 16(1): 171-182.
[30] Zhang Z, Xiao Y, Zhao J, et al. Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer[J]. Respirology, 2016, 21(3): 519-525.
[31] Sparano J, O'Neill A, Alpaugh K, et al. Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer: a secondary analysis of a randomized clinical trial[J]. JAMA Oncol, 2018. doi:10.1001/jamaoncol.2018.2574.
[32] Heller G, McCormack R, Kheoh T, et al. Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer: a comparison with prostate-specific antigen across five randomized phase iii clinical trials[J]. J Clin Oncol, 2018, 36(6): 572-580.
[33] Hong X, Sullivan R, Kalinich M, et al. Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy[J]. Proc Natl Acad Sci USA, 2018, 115(10): 2467-2472.
[34] Alix-Panabières C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor dna as liquid biopsy[J]. Cancer Discov, 2016, 6(5): 479-491.
[35] Gkountela S, Aceto N. Stem-like features of cancer cells on their way to metastasis[J]. Biol Direct, 2016, 11: 33-46. doi:10.1186/s13062-016-0135-4.
[1] GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan. Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 79-86.
[2] LIU Dongke, WANG Fengshan. Identification of heparin and heparan sulfate by HILIC-MS/MS [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 41-47.
[3] YANG Siyu, YAN Xiaona, PENG Jing, ZHANG Jie, WANG Yongxing, ZHANG Xinye, ZHANG Shufang. Pollution characteristics and health risk assessment of metals and metalloids in PM2.5 in two districts of Zhengzhou [J]. Journal of Shandong University (Health Sciences), 2021, 59(12): 70-77.
[4] XU Youwei, ZHOU Honglei, REN Dongmei, LOU Hongxiang, SHEN Tao. Chemical constituents from the aerial parts of Litsea glutinosa(Lour.)C.B. Rob. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 45-49.
[5] CHEN Wenbiao, YU Xiangqi, DAI Yong. Different expressions of novel microRNAs of iPSCs from Alport syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 80-85.
[6] WANG Meizhu, CAO Yu, ZHAO Liang, XU Xiaoshan, ZHANG Peifang, LV Qian, BAI Fengyan, KANG Yingqian. Composition and distribution of clinical yeasts in Guizhou region, China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 94-97.
[7] WANG Zhi-gang， JIANG Bin， MENG Qing-hu， HAO Xiao-guang， DING Xuan， LI Ji-sen. Isolation of human glioma-derived stem cells and
establishment of an invasive glioma model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 60-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd